SMTL ID : 5jsa.1

Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 6.31 Å

Oligo State

hetero-3-3-3-3-3-3-mer

Ligands

9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: R.112 Chain C: N.117, S.119, Y.134, D.289 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 4 residues within 4Å: Chain C: V.143, R.161, N.166 Chain O: R.277 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain C: N.354, S.356 Ligands: NAG-NAG-BMA.9, NAG-NAG-BMA.10 No protein-ligand interaction detected (PLIP) NAG-NAG.18: 5 residues within 4Å: Chain G: R.112 Chain I: N.117, S.119, Y.134, D.289 No protein-ligand interaction detected (PLIP) NAG-NAG.19: 4 residues within 4Å: Chain C: R.277 Chain I: V.143, R.161, N.166 No protein-ligand interaction detected (PLIP) NAG-NAG.20: 4 residues within 4Å: Chain I: N.354, S.356 Ligands: NAG-NAG-BMA.26, NAG-NAG-BMA.27 No protein-ligand interaction detected (PLIP) NAG-NAG.35: 5 residues within 4Å: Chain M: R.112 Chain O: N.117, S.119, Y.134, D.289 No protein-ligand interaction detected (PLIP) NAG-NAG.36: 4 residues within 4Å: Chain I: R.277 Chain O: V.143, R.161, N.166 No protein-ligand interaction detected (PLIP) NAG-NAG.37: 4 residues within 4Å: Chain O: N.354, S.356 Ligands: NAG-NAG-BMA.43, NAG-NAG-BMA.44 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.4: 9 residues within 4Å: Chain C: N.245, T.247, N.248 Chain E: Q.1, H.3, V.5, Q.6, Y.25, G.26 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:Q.1, E:H.3, E:Q.6 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.21: 9 residues within 4Å: Chain I: N.245, T.247, N.248 Chain K: Q.1, H.3, V.5, Q.6, Y.25, G.26 1 PLIP interactions: 1 interactions with chain K Hydrogen bonds: K:Q.1, K:H.3, K:Q.6 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.38: 9 residues within 4Å: Chain O: N.245, T.247, N.248 Chain Q: Q.1, H.3, V.5, Q.6, Y.25, G.26 1 PLIP interactions: 1 interactions with chain Q Hydrogen bonds: Q:H.3, Q:Q.6

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.5: 16 residues within 4Å: Chain A: Y.59, W.60, G.63, W.64, T.65, Y.66, H.67 Chain B: V.89, G.90, N.91, W.92, D.93 Chain C: T.266, H.298, N.300, S.380 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.22: 16 residues within 4Å: Chain G: Y.59, W.60, G.63, W.64, T.65, Y.66, H.67 Chain H: V.89, G.90, N.91, W.92, D.93 Chain I: T.266, H.298, N.300, S.380 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.39: 16 residues within 4Å: Chain M: Y.59, W.60, G.63, W.64, T.65, Y.66, H.67 Chain N: V.89, G.90, N.91, W.92, D.93 Chain O: T.266, H.298, N.300, S.380 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.6: 10 residues within 4Å: Chain A: S.28, A.30, H.55, A.57, S.58, T.81 Chain C: N.270, T.272 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.7, NAG-NAG-BMA-MAN-MAN-MAN-MAN.7 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.81 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.23: 10 residues within 4Å: Chain G: S.28, A.30, H.55, A.57, S.58, T.81 Chain I: N.270, T.272 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.24, NAG-NAG-BMA-MAN-MAN-MAN-MAN.24 2 PLIP interactions: 2 interactions with chain G Hydrogen bonds: G:T.81, G:T.81 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.40: 10 residues within 4Å: Chain M: S.28, A.30, H.55, A.57, S.58, T.81 Chain O: N.270, T.272 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.41, NAG-NAG-BMA-MAN-MAN-MAN-MAN.41 1 PLIP interactions: 1 interactions with chain M Hydrogen bonds: M:T.81

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.7: 15 residues within 4Å: Chain C: E.180, P.181, K.221, V.223, N.231, N.345, G.347, Q.407, G.408, V.409, V.413, S.414 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.6, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.6, NAG-NAG-BMA.12 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:G.347 NAG-NAG-BMA-MAN-MAN-MAN-MAN.24: 15 residues within 4Å: Chain I: E.180, P.181, K.221, V.223, N.231, N.345, G.347, Q.407, G.408, V.409, V.413, S.414 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.23, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.23, NAG-NAG-BMA.29 1 PLIP interactions: 1 interactions with chain I Hydrogen bonds: I:G.347 NAG-NAG-BMA-MAN-MAN-MAN-MAN.41: 15 residues within 4Å: Chain O: E.180, P.181, K.221, V.223, N.231, N.345, G.347, Q.407, G.408, V.409, V.413, S.414 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.40, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.40, NAG-NAG-BMA.46 1 PLIP interactions: 1 interactions with chain O Hydrogen bonds: O:G.347

3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.8: 4 residues within 4Å: Chain C: N.264, N.300, V.301, S.302 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.25: 4 residues within 4Å: Chain I: N.264, N.300, V.301, S.302 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.42: 4 residues within 4Å: Chain O: N.264, N.300, V.301, S.302 No protein-ligand interaction detected (PLIP)

15 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.9: 5 residues within 4Å: Chain C: N.331, N.354, S.356 Ligands: NAG-NAG.3, NAG-NAG.3 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.10: 2 residues within 4Å: Chain C: N.360 Ligands: NAG-NAG.3 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.11: 3 residues within 4Å: Chain C: K.303, A.304, N.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.12: 4 residues within 4Å: Chain C: N.231, P.260, N.415 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.7 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.13: 4 residues within 4Å: Chain C: T.98, Q.100, S.119, N.121 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.26: 5 residues within 4Å: Chain I: N.331, N.354, S.356 Ligands: NAG-NAG.20, NAG-NAG.20 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.27: 2 residues within 4Å: Chain I: N.360 Ligands: NAG-NAG.20 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.28: 3 residues within 4Å: Chain I: K.303, A.304, N.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.29: 4 residues within 4Å: Chain I: N.231, P.260, N.415 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.24 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.30: 4 residues within 4Å: Chain I: T.98, Q.100, S.119, N.121 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.43: 5 residues within 4Å: Chain O: N.331, N.354, S.356 Ligands: NAG-NAG.37, NAG-NAG.37 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.44: 2 residues within 4Å: Chain O: N.360 Ligands: NAG-NAG.37 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.45: 3 residues within 4Å: Chain O: K.303, A.304, N.307 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.46: 4 residues within 4Å: Chain O: N.231, P.260, N.415 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.41 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.47: 4 residues within 4Å: Chain O: T.98, Q.100, S.119, N.121 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.14: 6 residues within 4Å: Chain D: N.115 Chain F: N.32, Y.50, R.51, A.53, A.54 1 PLIP interactions: 1 interactions with chain F Hydrogen bonds: F:Y.50 NAG-NAG-BMA-MAN.31: 6 residues within 4Å: Chain J: N.115 Chain L: N.32, Y.50, R.51, A.53, A.54 1 PLIP interactions: 1 interactions with chain L Hydrogen bonds: L:Y.50 NAG-NAG-BMA-MAN.48: 6 residues within 4Å: Chain P: N.115 Chain R: N.32, Y.50, R.51, A.53, A.54 2 PLIP interactions: 2 interactions with chain R Hydrogen bonds: R:Y.50, R:Y.50

3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.15: 25 residues within 4Å: Chain C: K.201, N.203, I.246, H.320 Chain E: T.19, W.55, S.57, S.58, A.59, F.63, R.64, G.65, R.66, V.67, L.68, I.69, S.70, A.71, V.72, D.73, L.74, I.81, S.82, S.83, E.85 5 PLIP interactions: 5 interactions with chain E Hydrogen bonds: E:D.73, E:A.71, E:S.57, E:A.59, E:R.66, E:V.67, E:I.69 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.32: 25 residues within 4Å: Chain I: K.201, N.203, I.246, H.320 Chain K: T.19, W.55, S.57, S.58, A.59, F.63, R.64, G.65, R.66, V.67, L.68, I.69, S.70, A.71, V.72, D.73, L.74, I.81, S.82, S.83, E.85 5 PLIP interactions: 5 interactions with chain K Hydrogen bonds: K:D.73, K:A.71, K:S.57, K:A.59, K:R.66, K:V.67, K:I.69 NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.49: 25 residues within 4Å: Chain O: K.201, N.203, I.246, H.320 Chain Q: T.19, W.55, S.57, S.58, A.59, F.63, R.64, G.65, R.66, V.67, L.68, I.69, S.70, A.71, V.72, D.73, L.74, I.81, S.82, S.83, E.85 5 PLIP interactions: 5 interactions with chain Q Hydrogen bonds: Q:D.73, Q:A.71, Q:S.57, Q:A.59, Q:R.66, Q:V.67, Q:I.69

6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.16: 5 residues within 4Å: Chain C: N.103, R.112, K.116, R.139, K.158 6 PLIP interactions: 6 interactions with chain C Hydrogen bonds: C:N.103, C:R.112, C:K.116, C:K.158, C:K.158, C:K.158 NAG.17: 2 residues within 4Å: Chain D: N.89, S.91 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:N.89, D:S.91 NAG.33: 5 residues within 4Å: Chain I: N.103, R.112, K.116, R.139, K.158 6 PLIP interactions: 6 interactions with chain I Hydrogen bonds: I:N.103, I:R.112, I:K.116, I:K.158, I:K.158, I:K.158 NAG.34: 2 residues within 4Å: Chain J: N.89, S.91 2 PLIP interactions: 2 interactions with chain J Hydrogen bonds: J:N.89, J:S.91 NAG.50: 5 residues within 4Å: Chain O: N.103, R.112, K.116, R.139, K.158 6 PLIP interactions: 6 interactions with chain O Hydrogen bonds: O:N.103, O:R.112, O:K.116, O:K.158, O:K.158, O:K.158 NAG.51: 2 residues within 4Å: Chain P: N.89, S.91 2 PLIP interactions: 2 interactions with chain P Hydrogen bonds: P:N.89, P:S.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kong, L. et al., Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. Nat Commun (2016)

Release Date

2016-07-13

Peptides

broadly neutralizing antibody PGT128 heavy chain: AGM
broadly neutralizing antibody PGT128 light chain: BHN
gp120: CIO
gp41: DJP
broadly neutralizing antibody 8ANC195 heavy chain: EKQ
broadly neutralizing antibody 8ANC195 light chain: FLR

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

G
A

M
A

B
B

H
B

N
B

C
C

I
C

O
C

D
D

J
D

P
D

E
E

K
E

Q
E

F
F

L
F

R
F

broadly neutralizing antibody PGT128 heavy chain

broadly neutralizing antibody PGT128 light chain

gp120

gp41

broadly neutralizing antibody 8ANC195 heavy chain

broadly neutralizing antibody 8ANC195 light chain

Related Entries With Identical Sequence